insulin human + basal insulin

This is a **combination therapy** comprising **human insulin** and a **basal insulin**. Human insulin is a recombinant form of the naturally occurring hormone insulin, regulating glucose metabolism by facilitating cellular glucose uptake and inhibiting hepatic glucose output. "Basal insulin" refers to **long-acting formulations** (such as insulin glargine, insulin detemir, or NPH insulin), which provide steady insulin levels to control blood sugar between meals and overnight. The mechanism of action involves **agonism of the insulin receptor**, leading to enhanced glucose uptake and reduced hepatic glucose production. The primary indication is **diabetes mellitus** (Type 1 and Type 2), particularly when intensified insulin management is required. This combination allows both prandial and basal glycemic control, either as separate injections or in some formulations as a fixed ratio (sometimes called "basal plus" therapy). Combination therapy may reduce the risk of hypoglycemia and weight gain versus more complex insulin regimens[2][3][4].